University of Alabama at Birmingham: Communicable Diseases trials

The registry lists 11 Communicable Diseases studies with University of Alabama at Birmingham as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 1Phase 2 2Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Early Protein Supplementation in Extremely Preterm Infants Fed Human MilkActive, not recruitingNCT04325308Not applicableResults posted
• Conversion to Envarsus Post Kidney Transplant Protects Against BK InfectionCompletedNCT03762473Phase 2Results posted
• Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic VariationCompletedNCT03443791Not applicableResults posted
• Preadmission Skin Wipe Use for Surgical Site Infection Prophylaxis in Adult Orthopaedic Surgery PatientsTerminatedNCT03401749Phase 4Results posted
• Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) InfectionCompletedNCT01602614Results posted
• Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 InfectionCompletedNCT00734344Not applicableResults posted
• Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight NeonatesTerminatedNCT00599053Phase 1/2Results posted
• Comparing Modes of Telehealth Delivery: Phone vs. Video Visits (ASSIST)CompletedNCT04616118Not applicable
• Immune Profiles in CF Fungal InfectionCompletedNCT04476758
• Comparison of Standard of Care Guidelines for Mycoplasma Genitalium Infections Among Men With Non-gonococcal UrethritisTerminatedNCT03910907
• Sexually Transmitted Infections Among African American Women Who Have Sex With WomenCompletedNCT01546714